Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2018

Conditions
Peripheral Arterial Diseases
Interventions
DRUG

Dexamethasone Sodium Phosphate Injection, USP

Adventitial infusion of dexamethasone after angioplasty or atherectomy-based revascularization of the superficial femoral or popliteal artery.

Trial Locations (38)

10001

Gotham Cardiovascular Research / New York Cardiovascular Associates, New York

10032

Columbia University Medical Center, New York

12208

Albany Vascular Group, Albany

15232

UPMC Heart & Vascular Institute, Pittsburgh

20010

MedStar Health Washington Hospital Center, Washington D.C.

27607

UNC Health Care - Rex Hospital, Raleigh

32216

First Coast Cardiovascular Institute, Jacksonville

32504

Coastal Vascular & Interventional, Pensacola

34471

Munroe Regional Medical Center, Ocala

37660

Wellmont CVA Heart Institute, Kingsport

39216

University of Mississippi Medical Center, Jackson

39401

Hattiesburg Clinic, Hattiesburg

43214

OhioHealth, Columbus

46802

St. Joseph Hospital, Fort Wayne

48326

St. John Providence Hospital and Medical Center, Detroit

63110

St.Louis University Hospital, St Louis

71103

Willis-Knighton Medical Center, Shreveport

72211

Arkansas Heart Hospital, Little Rock

75208

DFW Vascular Group, Dallas

75801

Palestine Regional Medical Center, Palestine

76104

Plaza Medical Center at Fort Worth, Fort Worth

78155

Mission Research Institute (Guadalupe Regional Medical Center), Seguin

80220

VA Eastern Colorado Healthcare System, Denver

84041

Alpine Research / Utah Cardiology, Salt Lake City

85016

Arizona Heart Hospital / Abrazo Health Care Research / Tenet Health, Phoenix

85718

Pima Vascular, Tucson

90210

Cardiovascular Medical Group of Southern California / Cardiovascular Research Foundation, Beverly Hills

92868

St. Joseph Hospital of Orange Heart and Vascular Center, Orange

94121

San Francisco VA Medical Center, San Francisco

94131

University of California San Francisco Medical Center, San Francisco

98195

University of Washington Veterans Center, Seattle

06702

Hartford Hospital, Hartford

01655

UMass Medical School, Worcester

03766

Dartmouth-Hitchcock Medical Center, Lebanon

08015

Deborah Heart & Lung Center, Browns Mills

08822

Hunterdon Medical Center, Flemington

07103

Rutgers New Jersey Medical School, Newark

02906

The Miriam Hospital, Providence

Sponsors
All Listed Sponsors
lead

Mercator MedSystems, Inc.

INDUSTRY

NCT01983449 - Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease | Biotech Hunter | Biotech Hunter